Seeking to ramp up the nation’s capacity to administer a possible COVID-19 vaccine, the Trump administration has signed a $138 million deal with the makers of an innovative syringe designed to be used ...
FRANKLIN LAKES, N.J., Dec. 2, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest approximately $1.2 ...
NuTec’s Syringe Coating Machine Includes Four Epson G6 Cleanroom SCARA Robots to Precisely, Efficiently, and Cost-Effectively Automate Syringe Manufacturing. The OEM customer asked NuTec to develop a ...
Medtech giant BD has announced plans to invest more than $35 million and add approximately 50 new jobs to expand prefilled flush syringe manufacturing at its Columbus, NE, facility. The investments ...
BD, a leading global medical technology company, is investing more than $35 million to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility. With the investment, the company ...
FRANKLIN LAKES, N.J., Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest more than $35 million ...
Becton, Dickinson and Company will shell out $110 million to expand prefillable syringe production at its Columbus, Nebraska, manufacturing plant. The move comes in response to increasing delivery ...
7 October 2013 - Newcastle: Aesica, the global contract development and manufacturing organisation (CDMO), has extended its aseptic capabilities at its Nottingham site with the acquisition of new ...
(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Pre-Filled Syringes: End-to-End Processing Training Course" conference has been added to ResearchAndMarkets.com's ...
According to Mordor Intelligence, the global prefilled syringes market is experiencing strong expansion as healthcare systems increasingly prioritize safe, convenient, and accurate drug delivery ...
Seeking to ramp up the nation’s capacity to administer a possible COVID-19 vaccine, the Trump administration has signed a $138 million deal with the makers of an innovative syringe designed to be used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results